Further analyses were focused on evaluating the contribution of PON2 to sensitizing BC cells to the effect induced by chemotherapeutic treatment in terms of proliferative capacity, ROS production, and activation of caspase-3 and -8, which execute apoptosis. The gene discussed is PON2; the disease is breast cancer.